LEIDOS BIOMEDICAL RESEARCH, INC. recorded 1,162 award actions and $4,527,286,092.83 in obligated funding over the last 5 years, with all obligations coming from the National Institutes of Health. Most of the value was concentrated in NAICS 541715, research and development in the physical, engineering, and life sciences, while NAICS 561210 accounted for a smaller share tied to facilities support services.
Federal Contractor
LEIDOS BIOMEDICAL RESEARCH, INC. Federal Contract Obligations (Last 5 Years)
Federal procurement profile for LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6, UEI HV8BH9BPG8Y9) showing last 5 years of NIH obligations, award volume, and NAICS mix.
Annual obligations ranged from $552,024,126.52 in 2025 to $1,216,293,757.91 in 2023, based on readable FPDS data for the analysis window.
CAGE Code
3LYK6
UEI
HV8BH9BPG8Y9
Total Obligated
4.53 billion
4,527,286,092.83
Award Actions
1,162
Average Action Value
3,896,115.39
About LEIDOS BIOMEDICAL RESEARCH, INC. federal contract activity
LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6, UEI HV8BH9BPG8Y9) recorded 4.53 billion in obligated federal spending across 1,162 awards over the last 5 years, for an average award value of 3.90 million. The profile indicates a high-volume, high-dollar contracting history concentrated in a single federal customer base.
Agency mix and customer concentration
All identified obligations came from the NATIONAL INSTITUTES OF HEALTH, which accounted for the full 4.53 billion and all 1,162 awards in the analysis window. This extreme concentration indicates a single-agency dependence profile with no visible diversification across departments or components in the provided data.
Industry profile based on NAICS activity
Award activity is heavily concentrated in NAICS 541715, which captured 4.41 billion across 914 awards and represents the core of the vendor's federal work. NAICS 561210 contributed a much smaller 117.36 million across 248 awards, suggesting a secondary role tied to facilities support rather than the primary research and development mission.
Annual contract trend over the analysis window
Annual obligations peaked in 2023 at 1.22 billion, followed by 868.79 million in 2024 and 552.02 million in 2025. The sequence shows strong funding in 2021 and 2022 as well, with all five years remaining at substantial levels and annual award counts ranging from 221 to 247.
How to interpret this page
This summary is based on FPDS award data for the last 5 years, using obligated dollars and award counts associated with the vendor's CAGE code and UEI. Agency, NAICS, and annual trend sections reflect only the values provided in the analysis window and should be interpreted as an obligation-based view of recorded federal contracting activity.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 7529 | NATIONAL INSTITUTES OF HEALTH | 4,527,286,092.83 | 4.53 billion | 1,162 |
Insight
Over the last 5 years, LEIDOS BIOMEDICAL RESEARCH, INC. (CAGE 3LYK6) has $4.53 billion in obligations across 1,162 awards, with an average award value of $3.90 million. Obligations are fully concentrated within a single agency, the National Institutes of Health, indicating complete agency dependence in this period. This pattern suggests the vendor’s federal portfolio is highly concentrated rather than diversified across multiple agencies.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 4,409,927,743.41 | 4.41 billion | 914 |
| 561210 | FACILITIES SUPPORT SERVICES | 117,358,349.42 | 117.36 million | 248 |
Insight
Over the last 5 years, LEIDOS BIOMEDICAL RESEARCH, INC. received 4.53 billion across 1,162 awards, with an average award value of 3.90 million. Obligations are highly concentrated in NAICS 541715, which accounts for 4.41 billion and 914 awards, or the vast majority of both dollars and award volume. NAICS 561210 is a much smaller secondary category at 117.36 million across 248 awards, indicating limited diversification beyond research and development and a smaller facilities support portfolio.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '3LYK6'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 552,024,126.52 | 552.02 million | 221 |
| 2024 | 868,786,229.92 | 868.79 million | 225 |
| 2023 | 1,216,293,757.91 | 1.22 billion | 242 |
| 2022 | 953,445,462.23 | 953.45 million | 247 |
| 2021 | 936,736,516.25 | 936.74 million | 227 |
Insight
Over the last 5 years, LEIDOS BIOMEDICAL RESEARCH, INC. obligated 4.53 billion across 1,162 awards, averaging about 3.90 million per award. Obligations were concentrated in 2023, which was the peak year at 1.22 billion, while 2024 and 2025 declined to 868.79 million and 552.02 million, respectively. Award volume remained relatively stable year to year, ranging from 221 to 247 awards, indicating that the volatility is driven more by obligation value than by award count.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 5 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.